MI-181 Modulates Cilia Length and Restores Cilia Length in Cells with Defective Shortened Cilia
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00186 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Ankur A Gholkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States. Hauptthemen laut MEDLINE: Cilia, Acetamides, Quinolines, Sulfonamides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Primary cilia are membrane-covered microtubule-based structures that protrude from the cell surface and are critical for cell signaling and homeostasis during human development and adulthood. Dysregulation of cilia formation, length, and function can lead to a spectrum of human diseases and syndromes known as ciliopathies. Although some genetic and chemical screens have been performed to define important factors that modulate cilia biogenesis and length control, there are currently no clinical treatments that restore cilia length in patients. We report that the microtubule-targeting agent MI-181(mitotic inhibitor-181) is a potent modulator of cilia length and biogenesis. Treatment of retinal pigment epithelial-1 cells with MI-181 induced an increase in the average size of cilia and in the percent ciliated cells under nonstarved conditions. Importantly, MI-181 was effective at rescuing cilia length and ciliation defects in cells that had been treated with the intraflagellar transport inhibitor Ciliobrevin D or the O-GlcNAc transferase inhibitor OSMI-1. Most importantly, MI-181 induced an increase in cilia length and restored ciliation in cells with compromised shortened cilia at low nanomolar concentrations and did not show an inhibitory response at high concentrations. Therefore, MI-181 represents a lead molecule for developing drugs targeting ciliopathies characterized by shortened cilia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.
- Department of Medicine Statistics Core, University of California, Los Angeles, California 90095, United States.
- Department of Medicine's Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, California 90095, United States.
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California 90095, United States.
- Molecular Biology Institute, University of California, Los Angeles, California 90095, United States.
ORCID-Profile: Jorge Z Torres
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of General Medical Sciences
Zitieren
APA
Gholkar, A. A., Gimeno, T. V., Edgemon, J. E., Sim, M. S., & Torres, J. Z. (2024). MI-181 Modulates Cilia Length and Restores Cilia Length in Cells with Defective Shortened Cilia. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00186
Vancouver
Gholkar AA, Gimeno TV, Edgemon JE, Sim MS, Torres JZ. MI-181 Modulates Cilia Length and Restores Cilia Length in Cells with Defective Shortened Cilia. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00186
BibTeX
@article{Gholkar2024,
author = {Gholkar, Ankur A and Gimeno, Thomas V and Edgemon, Jalie E and Sim, Myung Shin and Torres, Jorge Z},
title = {MI-181 Modulates Cilia Length and Restores Cilia Length in Cells with Defective Shortened Cilia},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00186}
}
EUVIMED